Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun:102:151-160.
doi: 10.1016/j.neurobiolaging.2021.01.030. Epub 2021 Feb 4.

Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age

Affiliations

Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age

Samantha L Allison et al. Neurobiol Aging. 2021 Jun.

Abstract

This study examined the effect of neurodegeneration, and its interaction with Alzheimer's disease (AD) cerebrospinal fluid biomarkers, on longitudinal verbal learning and memory performance in cognitively unimpaired (CU) late middle-aged adults. Three hundred and forty-two CU adults (cognitive baseline mean age = 58.4), with cerebrospinal fluid and structural MRI, completed 2-10 (median = 5) cognitive assessments. Learning and memory were assessed using the Rey Auditory Verbal Learning Test (RAVLT). We used sequential comparison of nested linear mixed effects models to analyze the data. Model selection preserved a significant ptau181/Aβ42 × global atrophy × age interaction; individuals with less global atrophy and lower ptau181/Aβ42 levels had less learning and delayed recall decline than individuals with more global atrophy and/or higher levels of ptau181/Aβ42. The hippocampal volume × age × ptau181/Aβ42 interaction was not significant. Findings suggest that in a sample of CU late middle-aged adults, individuals with AD biomarkers, global atrophy, or both evidence greater verbal learning and memory decline than individuals without either risk factor.

Keywords: Cerebrospinal fluid biomarkers; Global atrophy; Hippocampus; Preclinical Alzheimer's disease; Verbal learning; Verbal memory.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Immediate recall (sum of learning trials 1 through 5) from the Rey Auditory Verbal Learning Test. Lines depict model-predicted age trajectories for three values of ptau181/Aβ42: red represents +1 standard deviation from the mean; gray represents the mean value; blue represents −1 standard deviation from the mean. Each panel reflects the model fit at a particular value of global atrophy (columns; −1, 0, +1 SD from the mean) and hippocampal volume (rows; sim.). Model predictions were made assuming a male participant with 16.15 years of education (the mean level) and no prior exposure to the battery. Confidence bands reflect the standard error of prediction for each line. The overlaid scatter represents raw individual test score measurements within nine (3×3 panel) predictor value bins, grouped such that Zpredictor ≤ −0.5 (top/left), −0.5 < Zpredictor ≤ 0.5 (center/center), and Zpredictor > 0.5 (bottom/right).
Figure 2:
Figure 2:
Delayed recall from the Rey Auditory Verbal Learning Test. Lines depict model-predicted age trajectories for three values of ptau181/Aβ42: red represents +1 standard deviation from the mean; gray represents the mean value; blue represents −1 standard deviation from the mean. Each panel reflects the model fit at a particular value of global atrophy (columns; −1, 0, +1 SD from the mean) and hippocampal volume (rows; sim.). Model predictions were made assuming a male participant with 16.15 years of education (the mean level) and no prior exposure to the battery. Confidence bands reflect the standard error of prediction for each line. The overlaid scatter represents raw individual test score measurements within nine predictor value bins, grouped such that Zpredictor ≤ −0.5 (top/left), −0.5 < Zpredictor ≤ 0.5 (center/center), and Zpredictor > 0.5 (bottom/right).

Similar articles

Cited by

References

    1. Akaike H. (1987). Factor analysis and AIC. In Selected Papers of Hirotugu Akaike (pp. 371–386). Springer.
    1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, … Petersen RC (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 270–279. - PMC - PubMed
    1. Allison SL, Koscik RL, Cary P, Jonaitis EM, Chin N, Rowley HA, Zetterberg H, Blennow K, Carlsson CM, Asthana S, Bendlin BB, & Johnson SC (2019). Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer’s disease spectrum. NeuroImage: Clinical, 23, 101895. - PMC - PubMed
    1. Aschenbrenner AJ, Gordon BA, Benzinger TL, Morris JC, & Hassenstab JJ (2018). Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology, 10.1212/WNL.0000000000006075. - DOI - PMC - PubMed
    1. Bäckman L, Jones S, Berger A-K, Laukka EJ, & Small BJ (2005). Cognitive impairment in preclinical Alzheimer’s disease: A meta-analysis. Neuropsychology, 19(4), 520. - PubMed

Publication types

MeSH terms